Skip to main content

Want a detailed portfolio tracker?

Cel-Sci (CVM) P/E (2010 - 2026)

Cel-Sci (CVM) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Cel-Sci (CVM) P/E is -0.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cel-Sci (CVM)

YearP/EChange
2026-0.31-71.77%
2025-1.09+23.51%
2024-0.88-76.51%
2023-3.77+35.80%
2022-2.77-65.71%
2021-8.09-40.19%
2020-13.52+0.39%
2019-13.47+406.43%
2018-2.66-63.09%
2017-7.21+12.49%
2016-6.41-81.84%
2015-35.27+18.15%
2014-29.85+50.90%
2013-19.78-61.09%
2012-50.84+118.67%
2011-23.25-90.08%
2010-234.33N/A

Comparison Cel-Sci (CVM) P/E with competitors

Cel-Sci (CVM) P/E is -0.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.55%
NBYStablecoin Development Corp0.10-133.13%
ENLVEnlivex Therapeutics Ltd0.15-148.68%
FGENFibroGen Inc0.24-177.80%
TRAWTraws Pharma Inc0.47-253.25%
FBIOFortress Biotech Inc0.71-328.84%
CHRSCoherus Biosciences Inc0.98-417.03%
ORMPOramed Pharmaceuticals Inc1.47-577.58%
AGENAgenus Inc2.05-763.95%
VIVSVivoSim Labs Inc2.54-921.90%
INVAInnoviva Inc3.19-1133.46%
CRMDCorMedix Inc3.65-1281.66%
ABEOAbeona Therapeutics Inc4.20-1462.94%
VXRTVaxart Inc4.26-1481.29%
CVACCureVac N.V.4.45-1540.93%
SRPTSarepta Therapeutics Inc4.62-1598.82%
GLPGGalapagos NV4.86-1674.86%
RIGLRigel Pharmaceuticals4.92-1694.53%
ZVRAZevra Therapeutics Inc4.97-1712.20%
ABUSArbutus Biopharma Corp5.69-1945.48%
CGENCompugen Ltd7.38-2493.33%
AUPHAurinia Pharmaceuticals Inc9.25-3098.64%
ACADAcadia Pharmaceuticals Inc9.59-3207.75%
OMEROmeros Corporation9.88-3303.49%
PLXProtalix BioTherapeutics Inc9.91-3311.82%
SPROSpero Therapeutics Inc10.73-3579.43%
ADMAAdma Biologics Inc11.33-3772.58%
SVASinovac Biotech Ltd11.44-3806.74%
TBPHTheravance Biopharma Inc11.78-3917.14%
HRMYHarmony Biosciences Holdings Inc12.18-4048.02%
TGTXTG Therapeutics Inc13.18-4371.83%
INCYIncyte Corp13.38-4437.50%
SABSSAB Biotherapeutics Inc14.06-4656.52%
XOMAXOMA Corp14.95-4944.18%
REGNRegeneron Pharmaceuticals Inc14.98-4955.53%
PBYIPuma Biotechnology Inc15.05-4978.28%
EXELExelixis Inc15.79-5219.57%
NAGENiagen Bioscience Inc16.35-5401.11%
CPRXCatalyst Pharmaceuticals Inc17.34-5721.94%
MDXGMimedx Group Inc17.38-5731.86%
ARGXArgen X SE23.07-7578.18%
HALOHalozyme Therapeutics Inc23.20-7619.99%
XOMAOXOMA Corp25.34-8315.00%
VRTXVertex Pharmaceuticals Inc25.66-8415.80%
XOMAPXOMA Corp25.67-8420.44%
CTMXCytomX Therapeutics Inc25.70-8429.45%
ASNDAscendis Pharma A/S26.35-8642.14%
RPRXRoyalty Pharma plc - Class A27.50-9012.07%
SLNOSoleno Therapeutics Inc29.02-9504.72%
LGNDLigand Pharmaceuticals Inc - Class B30.19-9884.35%
BMRNBiomarin Pharmaceutical Inc37.51-12257.22%
APLSApellis Pharmaceuticals Inc39.02-12747.92%
KRYSKrystal Biotech Inc39.70-12967.16%
GMABGenmab40.20-13131.18%
ONCBeiGene Ltd67.03-21825.43%
TECHBio-Techne Corp68.59-22333.70%
VCELVericel Corp80.63-26234.34%
PHARPharming Group N.V.87.74-28539.21%
ALNYAlnylam Pharmaceuticals Inc124.93-40594.75%
TLXTelix Pharmaceuticals Ltd139.89-45442.76%
CORTCorcept Therapeutics Inc158.39-51438.71%